Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent c
Harga saat ini dari N6B.MU adalah €220.1 EUR — turun sebesar -1.68% dalam 24 jam terakhir. Pantau kinerja harga saham Labcorp lebih dekat di grafik.
Apa simbol saham Labcorp?▼
Tergantung pada bursa, simbol saham dapat berbeda. Misalnya, di bursa , saham Labcorp diperdagangkan dengan simbol N6B.MU.
Apakah harga saham Labcorp sedang naik?▼
Saham N6B.MU turun -3.04% dibandingkan minggu sebelumnya, turun -5.94% selama sebulan terakhir, namun dalam setahun terakhir Labcorp menunjukkan kenaikan +1.9%.
Kapan tanggal laporan keuangan berikutnya dari Labcorp?▼
Labcorp akan merilis laporan keuangan berikutnya pada Juli 30, 2026.
Bagaimana laporan keuangan Labcorp pada kuartal lalu?▼
Laporan keuangan N6B.MU untuk kuartal terakhir adalah 3.62 EUR per saham, sedangkan perkiraannya 3.5 EUR, menghasilkan kejutan sebesar +3.42%. Perkiraan laba untuk kuartal berikutnya adalah N/A EUR per saham.
Apakah Labcorp membayar dividen?▼
Ya, dividen N6B.MU dibayarkan triwulanan. Dividen terakhir per saham adalah 0.61 EUR. Per hari ini, Dividend Yield (FWD)% adalah 1.12%.
Berapa jumlah karyawan Labcorp?▼
Per Mei 06, 2026, perusahaan memiliki 67,000 karyawan.
Labcorp berada di sektor apa?▼
Labcorp beroperasi di sektor Kesehatan & Kebugaran.
Kapan Labcorp menyelesaikan split saham?▼
Labcorp belum melakukan split saham baru-baru ini.
Di mana kantor pusat Labcorp?▼
Kantor pusat Labcorp berlokasi di Burlington, Amerika Serikat.